Rangeley Capital, LLC

SEC CIK: 0001517796
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

ESPR holding history

Esperion Therapeutics, Inc. in every 13F filed by Rangeley Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ESPR overview All 13F holders of ESPR Full Q2 2026 holdings

Shares (Q2 2026): 62,000
Value: $195.9K
% of portfolio: 0.2%
Quarters held: 3; Since Q4 2024

Holdings of ESPR by Rangeley Capital, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	62,000	$195.9K	0.2%	+62,000	New	Holders
Q2 2025	0	$0	0.0%	−92,500−100.0%	Sold out	Holders
Q1 2025	92,500	$133.2K	0.2%	−14,500−13.6%	Reduced	Holders
Q4 2024	107,000	$235.4K	0.2%	–	No prior filing	Holders